Exchange: NASDAQ·Updated 04:10 PM EST

About DYAI

About

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
5

Frequently Asked Questions

Advertisement|Remove ads.